Committee header
Active cycles
Panel 2 • Finance overview
Committee finance snapshot
Scope: All time
Money over time
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 68.4% of total raised.
Dominant category: Operations at 91.2% of spending.
Donor count
898
Contributions
1,814
Median
$310
Average
$1,289
Funding distribution
$5,000+
Count: 233
Share: 68.4%
Amount: $1,599,500
$1,000 - $4,999
Count: 222
Share: 18.3%
Amount: $427,467
$500 - $999
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageCommittee header
Active cycles
Panel 2 • Finance overview
Committee finance snapshot
Scope: All time
Money over time
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 68.4% of total raised.
Dominant category: Operations at 91.2% of spending.
Donor count
898
Contributions
1,814
Median
$310
Average
$1,289
Funding distribution
$5,000+
Count: 233
Share: 68.4%
Amount: $1,599,500
$1,000 - $4,999
Count: 222
Share: 18.3%
Amount: $427,467
$500 - $999
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageCount: 147
Share: 3.9%
Amount: $90,653
$100 - $499
Count: 1,104
Share: 10.5%
Amount: $246,660
$1 - $99
Count: 95
Share: 0.2%
Amount: $5,790
Spending categories
Operations
Amount: $2,000,099
Share: 91.2%
Consulting
Amount: $168,050
Share: 7.7%
Field
Amount: $23,522
Share: 1.1%
Media
Amount: $310
Share: 0%
Refunds and adjustments: 11 entries, -$31,700 total.
Count: 147
Share: 3.9%
Amount: $90,653
$100 - $499
Count: 1,104
Share: 10.5%
Amount: $246,660
$1 - $99
Count: 95
Share: 0.2%
Amount: $5,790
Spending categories
Operations
Amount: $2,000,099
Share: 91.2%
Consulting
Amount: $168,050
Share: 7.7%
Field
Amount: $23,522
Share: 1.1%
Media
Amount: $310
Share: 0%
Refunds and adjustments: 11 entries, -$31,700 total.
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | $123,700 | 5.3% | 21 | May 28, 2025 |
| AMGEN, INC. | $74,400 | 3.2% | 9 | Apr 29, 2025 |
| GENENTECH, INC. | $72,300 | 3.1% | 9 | Jun 16, 2025 |
| ABBOTT LABORATORIES EMPLOYEE PAC | $56,800 | 2.4% | 10 | Jul 18, 2025 |
| JOHNSON & JOHNSON | $54,900 | 2.3% | 7 | Sep 23, 2024 |
| EDWARDS LIFESCIENCES CORPORATION | $52,600 | 2.2% | 7 | Jan 31, 2024 |
| MASIMO CORPORATION | $50,000 | 2.1% | 6 | Apr 28, 2025 |
| PFIZER, INC. | $45,000 | 1.9% | 9 | Mar 30, 2022 |
| NEKTAR THERAPEUTICS | $38,717 | 1.7% | 14 | Mar 31, 2025 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | $37,050 | 1.6% | 7 | Oct 18, 2020 |
| EDWARDS LIFESCIENCES | $34,225 | 1.5% | 7 | Dec 18, 2014 |
| PFIZER, INC | $32,100 | 1.4% | 6 | Aug 2, 2016 |
| BIOMARIN PHARMACEUTICAL INC. | $31,800 | 1.4% | 6 | Jul 9, 2024 |
| ALLERGAN SPECIALTY THERAPEUTICS, INC. | $30,100 | 1.3% | 6 | Sep 26, 2019 |
| ALLERGAN | $29,160 | 1.2% | 6 | Dec 14, 2015 |
| TAKEDA PHARMACEUTICALS USA, INC. | $28,900 | 1.2% | 4 | Sep 15, 2020 |
| MEDTRONIC, INC. | $26,800 | 1.1% | 4 | Feb 24, 2015 |
| ALLERGAN | $25,500 | 1.1% | 4 | Jan 31, 2012 |
| EDWARDS LIFESCIENCES | $25,500 | 1.1% | 5 | Jan 4, 2012 |
| GENENTECH | $24,100 | 1% | 4 | Jan 31, 2012 |
| ACADIA PHARMACEUTICALS | $23,900 | 1% | 3 | Sep 15, 2025 |
| EXELIXIS, INC. | $23,200 | 1% | 3 | Oct 23, 2022 |
| JOHNSON & JOHNSON | $22,869 | 1% | 5 | Sep 24, 2015 |
| BOEHRINGER - INGELHEIM PHARMACEUTICALS, INC. | $22,300 | 1% | 5 | Apr 14, 2016 |
| GENENTECH, INC. | $21,310 | 0.9% | 4 | Feb 24, 2015 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | $123,700 | 5.3% | 21 | May 28, 2025 |
| AMGEN, INC. | $74,400 | 3.2% | 9 | Apr 29, 2025 |
| GENENTECH, INC. | $72,300 | 3.1% | 9 | Jun 16, 2025 |
| ABBOTT LABORATORIES EMPLOYEE PAC | $56,800 | 2.4% | 10 | Jul 18, 2025 |
| JOHNSON & JOHNSON | $54,900 | 2.3% | 7 | Sep 23, 2024 |
| EDWARDS LIFESCIENCES CORPORATION | $52,600 | 2.2% | 7 | Jan 31, 2024 |
| MASIMO CORPORATION | $50,000 | 2.1% | 6 | Apr 28, 2025 |
| PFIZER, INC. | $45,000 | 1.9% | 9 | Mar 30, 2022 |
| NEKTAR THERAPEUTICS | $38,717 | 1.7% | 14 | Mar 31, 2025 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | $37,050 | 1.6% | 7 | Oct 18, 2020 |
| EDWARDS LIFESCIENCES | $34,225 | 1.5% | 7 | Dec 18, 2014 |
| PFIZER, INC | $32,100 | 1.4% | 6 | Aug 2, 2016 |
| BIOMARIN PHARMACEUTICAL INC. | $31,800 | 1.4% | 6 | Jul 9, 2024 |
| ALLERGAN SPECIALTY THERAPEUTICS, INC. | $30,100 | 1.3% | 6 | Sep 26, 2019 |
| ALLERGAN | $29,160 | 1.2% | 6 | Dec 14, 2015 |
| TAKEDA PHARMACEUTICALS USA, INC. | $28,900 | 1.2% | 4 | Sep 15, 2020 |
| MEDTRONIC, INC. | $26,800 | 1.1% | 4 | Feb 24, 2015 |
| ALLERGAN | $25,500 | 1.1% | 4 | Jan 31, 2012 |
| EDWARDS LIFESCIENCES | $25,500 | 1.1% | 5 | Jan 4, 2012 |
| GENENTECH | $24,100 | 1% | 4 | Jan 31, 2012 |
| ACADIA PHARMACEUTICALS | $23,900 | 1% | 3 | Sep 15, 2025 |
| EXELIXIS, INC. | $23,200 | 1% | 3 | Oct 23, 2022 |
| JOHNSON & JOHNSON | $22,869 | 1% | 5 | Sep 24, 2015 |
| BOEHRINGER - INGELHEIM PHARMACEUTICALS, INC. | $22,300 | 1% | 5 | Apr 14, 2016 |
| GENENTECH, INC. | $21,310 | 0.9% | 4 | Feb 24, 2015 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.